Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a specialized treatment for certain abdominal tumors. The purpose of HIPEC treatment is to kill microscopic cancer cells invisible to the human eye and reduce cancer recurrence.
HIPEC surgery combines removal of abdominal tumors with a single dose of chemotherapy warmed to 107 degrees and inserted directly into the abdominal cavity at the location of the tumor. The combination of heat and chemotherapy can kill cancer cells and prevent tumor recurrences. The medication does not cross into the bloodstream, which minimizes potential side effects and allows for a higher, more effective dose of chemotherapy than would be possible if given intravenously (IV). At the end of surgery, the chemotherapy is removed and the abdominal cavity is cleansed before the incision is closed.
HIPEC is designed to treat tumors that have spread within the abdominal cavity but do not invade other organs such as the liver, lungs or bone. There are many types of tumors that are potentially treatable with HIPEC. Candidacy for HIPEC surgery is made on an individual basis. Some of the more commonly treated tumors include:
Because many of the tumor types treated by HIPEC are rare, it is not unusual for confusion, doubt and uncertainty to cloud the diagnosis and recommended treatment before seeing a HIPEC surgeon. Because UCLA is experienced in treating these rare diseases, we can diagnose and treat the condition while avoiding unnecessary tests and delays.